# Influence of Central Obesity on the Esophageal Epithelial Barrier

> **NCT02776982** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 38 (actual)

## Conditions studied

- Gastroesophageal Reflux
- GERD

## Interventions

- **PROCEDURE:** Confocal endomicroscopy
- **PROCEDURE:** Mucosal impedance
- **PROCEDURE:** Research biopsies
- **PROCEDURE:** Bravo ambulatory pH monitor

## Key facts

- **NCT ID:** NCT02776982
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-05-16
- **Final completion:** 2019-05-16
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02776982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02776982, "Influence of Central Obesity on the Esophageal Epithelial Barrier". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02776982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*